Uric acid, chronic kidney disease and type 2 diabetes: A cluster of vascular risk factors

被引:20
作者
Athyros, Vasilios G. [1 ]
Mikhailidis, Dimitri P. [2 ]
机构
[1] Aristotle Univ Thessaloniki, Hippocrat Hosp, Propedeut Dept Internal Med 2, Atherosclerosis & Metab Syndrome Units, Thessaloniki, Greece
[2] UCL, Sch Med, Dept Clin Biochem, Vasc Dis Prevent Clin, London W1N 8AA, England
关键词
GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR RISK; RENAL-FUNCTION; STATINS; TRIAL;
D O I
10.1016/j.jdiacomp.2013.11.012
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
引用
收藏
页码:122 / 123
页数:2
相关论文
共 17 条
[1]
Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study [J].
Athyros, Vassilios G. ;
Karagiannis, Asterios ;
Ganotakis, Emmanouel S. ;
Paletas, Konstantinos ;
Nicolaou, Vassilios ;
Bacharoudis, George ;
Tziomalos, Konstantinos ;
Alexandrides, Theodore ;
Liberopoulos, Evangelos N. ;
Mikhailidis, Dimitri P. .
CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (08) :1659-1668
[2]
Statins and renal function in patients with diabetes mellitus [J].
Athyros, VG ;
Papageorgiou, AA ;
Elisaf, M ;
Mikhailidis, DP .
CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (07) :615-617
[3]
Pathogenesis and treatment of kidney disease and hypertension - Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study [J].
Athyros, VG ;
Elisaf, M ;
Papageorgiou, AA ;
Symeonidis, AN ;
Pehlivanidis, AN ;
Bouloukos, VI ;
Milionis, HJ ;
Mikhailidis, DP .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) :589-599
[4]
Bellomo Gianni, 2013, World J Nephrol, V2, P17, DOI 10.5527/wjn.v2.i2.17
[5]
High-normal serum uric acid is associated with albuminuria and impaired glomerular filtration rate in Chinese type 2 diabetic patients [J].
Cai Xiao-ling ;
Han Xue-yao ;
Ji Li-nong .
CHINESE MEDICAL JOURNAL, 2011, 124 (22) :3629-3634
[6]
Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia [J].
Daskalopoulou, SS ;
Tzovaras, V ;
Mikhailidis, DP ;
Elisaf, M .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (32) :4161-4175
[7]
The impact of serum uric acid on cardiovascular outcomes in the LIFE study [J].
Daskalopoulou, SS ;
Athyros, VG ;
Elisaf, M ;
Mikhailidis, D .
KIDNEY INTERNATIONAL, 2004, 66 (04) :1714-1715
[8]
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999 [J].
Foley, RN ;
Murray, AM ;
Li, SL ;
Herzog, CA ;
McBean, AM ;
Eggers, PW ;
Collins, AJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02) :489-495
[9]
The ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid Trial What we learn from subgroup analyses [J].
Ginsberg, Henry N. .
DIABETES CARE, 2011, 34 :S107-S108
[10]
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk [J].
Goicoechea, Marian ;
Garcia de Vinuesa, Soledad ;
Verdalles, Ursula ;
Ruiz-Caro, Caridad ;
Ampuero, Jara ;
Rincon, Abraham ;
Arroyo, David ;
Luno, Jose .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (08) :1388-1393